GEMIGNANI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 13.640
AS - Asia 5.456
EU - Europa 4.407
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 581
AF - Africa 186
OC - Oceania 29
Totale 25.112
Nazione #
US - Stati Uniti d'America 13.320
SG - Singapore 1.787
IT - Italia 1.552
CN - Cina 1.426
HK - Hong Kong 909
BR - Brasile 681
SE - Svezia 588
DE - Germania 575
VN - Vietnam 489
BG - Bulgaria 339
GB - Regno Unito 263
FI - Finlandia 242
TR - Turchia 238
CA - Canada 223
FR - Francia 216
RU - Federazione Russa 181
IN - India 118
UA - Ucraina 114
KR - Corea 105
JP - Giappone 97
CI - Costa d'Avorio 62
NL - Olanda 58
BD - Bangladesh 51
AT - Austria 49
AR - Argentina 45
EE - Estonia 44
CH - Svizzera 41
MX - Messico 37
IQ - Iraq 35
BE - Belgio 34
MA - Marocco 30
PL - Polonia 29
ID - Indonesia 28
PK - Pakistan 27
AU - Australia 25
SA - Arabia Saudita 23
SN - Senegal 21
EC - Ecuador 19
ES - Italia 18
ZA - Sudafrica 18
CO - Colombia 16
CZ - Repubblica Ceca 13
JM - Giamaica 13
PH - Filippine 13
UZ - Uzbekistan 13
CL - Cile 12
JO - Giordania 12
CR - Costa Rica 11
KE - Kenya 11
MY - Malesia 11
PY - Paraguay 11
VE - Venezuela 11
HU - Ungheria 10
TN - Tunisia 10
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
NG - Nigeria 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
TW - Taiwan 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IR - Iran 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
PR - Porto Rico 5
TH - Thailandia 5
AL - Albania 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
IE - Irlanda 4
KG - Kirghizistan 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
LC - Santa Lucia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
Totale 24.509
Città #
Ashburn 1.462
Woodbridge 1.235
Fairfield 1.102
Ann Arbor 990
Singapore 953
Houston 921
Hong Kong 878
Dallas 673
San Jose 648
Santa Clara 629
Chandler 569
Seattle 502
Cambridge 398
Wilmington 357
Sofia 337
Serra 328
Shanghai 318
Beijing 288
Milan 282
New York 275
Council Bluffs 240
Boardman 206
Los Angeles 181
Munich 159
Princeton 153
Ottawa 145
Izmir 140
Medford 125
Lauterbourg 122
Lawrence 120
Hefei 118
Ho Chi Minh City 107
Helsinki 105
Pisa 101
Jacksonville 100
Florence 96
Seoul 95
Hanoi 90
Nanjing 88
Frankfurt am Main 86
Des Moines 84
Tokyo 84
London 72
San Diego 68
Buffalo 65
Istanbul 65
Dong Ket 64
Abidjan 62
Falls Church 59
Redondo Beach 53
Rome 52
São Paulo 52
Columbus 50
Washington 43
Lucca 41
Chicago 39
Bremen 37
Bern 35
Dearborn 35
Genoa 35
Phoenix 35
The Dalles 34
Brussels 32
Nanchang 30
Nuremberg 29
Vienna 29
Rio de Janeiro 26
Shenyang 26
Casablanca 25
San Francisco 25
Boulder 24
Warsaw 23
Ogden 22
Dakar 21
Kunming 21
Amsterdam 20
Lancaster 20
Lappeenranta 20
Guangzhou 19
Hebei 19
Livorno 19
Piombino 19
Belo Horizonte 18
Changsha 18
Fuzhou 18
Pune 18
Redwood City 18
Ternay 17
Toronto 17
Montreal 16
Norwalk 16
Detroit 15
Nürnberg 15
Turku 15
Da Nang 14
Dhaka 14
Jüchen 14
Orem 14
Atlanta 13
Auburn Hills 13
Totale 17.638
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 355
Maternal anthropometric variables and clinical factors shape neonatal microbiome 347
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 323
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 321
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 287
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 258
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 258
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 252
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 251
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 249
Identification of miRSNPs associated with the risk of multiple myeloma 248
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 247
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 239
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 229
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma. 227
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 225
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 225
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. 223
The genetic susceptibility in the development of malignant pleural mesothelioma 220
Inherited variants in genes somatically mutated in thyroid cancer 220
Chromosome aberrations in lymphocytes and clastogenic factors in plasma detected in Belarus children 10 years after Chernobyl accident. 219
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 216
Environmental risk factors for pancreatic cancer: an update. 215
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 213
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 213
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. 211
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 208
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 208
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 204
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 203
Benzodiazepine binding in T-lymphocytes from parkinsonian patients 202
Identificazione e caratterizzazione dei microRNA coinvolti nel Mesotelioma Pleurico Maligno 202
Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 202
Genome-wide association study on differentiated thyroid cancer. 199
More targets, more pathways and more clues for mutant p53. 198
Thrombocyte phenolsulphotransferase and monoamine oxidase activity, and benzodiazepine binding in patients with dementia of Alzheimer type 197
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 196
T-lymphocyte peripheral-type benzodiazepine binding in parkinsonian patients 195
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 195
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 194
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. 191
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 191
Prediction of the biological effect of polymorphisms within microRNA binding sites. 189
Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in SACS KO Cell Model 188
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk 188
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping 187
Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach 186
Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 184
COMPASSS (COMplex PAttern of Sequence Search Software), a simple and effective tool for mining complex motifs in whole genomes 184
Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with the serum levels of the mesothelin-related protein 184
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans 183
Cytogenetic damage in lymphocytes of healthy and thyroid tumor-affected children from the Gomel region (Belarus). 182
Correction: Inherited variants in genes somatically mutated in thyroid cancer 181
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect 180
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility 180
Chromosome aberrations in humans in relation to site of residence. 179
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 178
Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. 177
A Catalog of Polymorphisms Falling in MicroRNA-Binding Regions of Cancer Genes 177
DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses 176
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review 174
Platelet phenolsulphotransferase activity in patients with dementia of Alzheimer type 171
A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA 171
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer 171
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 171
A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility 170
Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair 170
Obesity and the Risk of Papillary Thyroid Cancer: A Pooled Analysis of Three Case-Control Studies. 168
Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. 166
Targeting hypoxic response for cancer therapy. 166
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 165
Development of a yeast-based system to identify new hBRAFV600E functional interactors 165
Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology 165
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. 164
High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA 163
Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding. 162
A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer 160
Platelet monoamine oxidase molecular activity in demented patients 159
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan 158
Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk 157
Identification of overexpressed genes in malignant pleural mesothelioma 157
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 155
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 154
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 154
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma 153
Runs of homozygosity and inbreeding in thyroid cancer 153
Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe 152
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. 151
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis 151
The importance of p53 pathway genetics in inherited and somatic cancer genomes 151
Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer 150
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 150
Monoamine oxidase molecular activity in thrombocytes of demented patients 149
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. 149
Germline genetic variability in pancreatic cancer risk and prognosis 149
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues 147
Spontaneous and MNNG-induced reversion of an EGFP construct in HeLa cells: an assay for observing mutations in living cells by fluorescent microscopy 147
A polygenic risk score for multiple myeloma risk prediction 146
Genetically determined telomere length and multiple myeloma risk and outcome 146
Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. 145
Totale 19.284
Categoria #
all - tutte 71.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.602 0 0 87 95 301 233 76 74 104 77 91 464
2022/20231.878 206 216 131 186 185 234 20 139 320 20 203 18
2023/20241.452 156 145 281 68 177 264 56 48 24 30 72 131
2024/20254.636 11 157 48 282 478 496 492 262 474 635 481 820
2025/20266.013 417 714 681 452 533 481 1.083 308 365 465 281 233
2026/2027936 146 416 374 0 0 0 0 0 0 0 0 0
Totale 25.112